"informational needs and the regulatory frame for consumer applications: the eu...
DESCRIPTION
Draft. "Informational needs and the regulatory frame for consumer applications: The EU Commission's view". Philippe Martin European Commission Directorate-General for Health and Consumers philippe.martin (at) ec.europa.eu CEFIC, Brussels, Tuesday, 24 June 2008. Outline. Introduction - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/1.jpg)
"Informational needs and the regulatory frame for
consumer applications: The EU Commission's view"
Philippe MartinEuropean Commission
Directorate-General for Health and Consumersphilippe.martin (at) ec.europa.eu
CEFIC, Brussels, Tuesday, 24 June 2008
![Page 2: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/2.jpg)
Outline
IntroductionApplicationsLegislative reviewRisk assessmentPublic dialogueConclusion
![Page 3: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/3.jpg)
Working definition of nanoscale“A feature characterised by dimensions of the
order of 100 nm or less” (SCENIHR, 2007)But,
size limits somewhat arbitraryno conflict with meaning of existing wordscertain physico-chemical properties to have major impact on behaviourincreased production requires consideration of potential new words and definitionsmay be necessary to distinguish between different sizes of NPs and molecules for a variety of reasons - does not imply greater toxicological, public health, or environmental health concern associated with any one size rangehierarchical etymological approach based on consideration of physical, chemical and biological fundamentals
![Page 4: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/4.jpg)
Legislative review adoptedCommissioner Androulla Vassiliou
responsible for Health said: “In today’s Europe, nanotechnologies must be developed in a safe, integrated and responsible way, involving all stakeholders so that new applications can result in real benefits for EU citizens in the area of health.”
![Page 5: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/5.jpg)
Targeted drug delivery systems
![Page 6: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/6.jpg)
Diagnostics
![Page 7: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/7.jpg)
Regenerative medicine
![Page 8: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/8.jpg)
Diseases of the nervous system
![Page 9: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/9.jpg)
![Page 10: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/10.jpg)
EU LegislationIndustrial new and existing chemicals (REACH)Pharmaceuticals, Pesticides, BiocidesMedical devices, Cosmetics, Food additives and packages Worker protection Air, Water, IPPC, Seveso, WasteEnvironment Liability, Product liability, Product safety
ENTR ENV SANCO EMPL
![Page 11: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/11.jpg)
Legislative review [COM(2008)366]
“Current legislation covers in principle the potential health and environmental risks in relation to nanomaterials”Associated informational needs:
Scientific knowledge gapsMarket surveillanceExposure, hazard, and risk assessment
Data generation: excellence, independence, transparency
![Page 12: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/12.jpg)
Risk assessmentSCENIHR & SCCP scientific opinions
Possible limits to adequacy of RA methods (cf., esp., percutaneous penetration, inhalation and ingestion, in vitro toxicology, ecotoxicology, environmental fate and effects)Dose metrics & dose-responseDe novo, case-by-case RA & new data
EFSA mandateRisksHazardsGuidance
![Page 13: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/13.jpg)
Issues relating to sources and type of NPs
naturally produced vs. engineered NPsNPs in matrix vs. free, insoluble NPsclassical physics + quantum mechanicsincreased surface to volume ratiosize, shape, number, surface areasurface chemistry, charge, topographychemical composition and stabilitysolubility, vapor pressure, etc.
![Page 14: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/14.jpg)
Issues Relating to Exposureroutes of exposure to NPsincreasing levels of exposuremechanisms and kineticssampling, detection, measurement, and characterisation of NPsvalidity of current environmental exposure modelsbackground data on the current and historic exposure levelsadditive effects of simultaneous exposure
![Page 15: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/15.jpg)
Issues Relating to Hazard Assessment
insufficiency of scientific informationphysico-chemical changes of NPstranslocation of NPsinteraction with living matterfate, distribution, and persistenceextrapolation of data from non-nano
![Page 16: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/16.jpg)
Issues Relating to the Risk Assessment Strategies
Include size, shape, surface area, # and ζExisting methods may be adequateNew testing methods may be neededCase-by-case approach
different exposure levelsnot all NPs exhibit higher toxicity than bulk formulationsmethodological uncertainties do not allow for extrapolation between NPsinsufficient toxicological data on NPs
![Page 17: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/17.jpg)
Cognition, informational asymmetry, and ethics
Object ChoiceObject
descriptionto one’s self
Beliefs Frame
![Page 18: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/18.jpg)
Public dialogue
Registration opens 1st week of July: http://ec.europa.eu/health/ph_risk/events_risk_en.htm
![Page 19: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/19.jpg)
Conclusion: Who provides what information to whom for which purpose?
Science: To advance understandingRisk assessment: To perform de novo, case-by-case RA using substance specific dataImplementation of regulation: To fulfill legal obligations and secure pre-market approvalPublic dialogue: To have an informed exchange
Thank you!
![Page 20: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/20.jpg)
Links on nanoLegislative review
Press Release on Public Dialogue: http://www.europa.eu/rapid/pressReleasesAction.do?reference=IP/08/947&format=HTML&aged=0&language=EN&guiLanguage=en Communication (2008)366: http://www.cc.cec/home/dgserv/sg/sgvista/i/sgv2/repo/repo.cfm?institution=COMM&doc_to_browse=COM/2008/0366&refresh_session=YESFAQs: http://ec.europa.eu/nanotechnology/faq/faq_en.cfm
Scientific OpinionsScientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) opinions on nanotechnologies http://ec.europa.eu/health/ph_risk/committees/04_scenihr/scenihr_opinions_en.htmScientific Committee on Consumer Products (SCCP) opinion on nanomaterials in cosmetics: http://ec.europa.eu/health/ph_risk/committees/04_sccp/sccp_opinions_en.htmEuropean Food Safety Authority (EFSA) information about risk assessment in the field of food and feed: http://www.efsa.europa.eu/EFSA/KeyTopics/efsa_locale-1178620753812_Nanotechnology.htm
2nd Annual Nanotechnology Safety for Success Dialogue Workshop in Brussels, Belgium, on 2-3 October 2008: http://ec.europa.eu/health/ph_risk/events_risk_en.htm
![Page 21: "Informational needs and the regulatory frame for consumer applications: The EU Commission's view"](https://reader036.vdocuments.mx/reader036/viewer/2022062719/5681320d550346895d986075/html5/thumbnails/21.jpg)
CoordinatesPhilippe Martin, PhDPrincipal AdministratorEuropean Commission Directorate-General for Health and ConsumersB232 2/12, B-1049 Brussels, Belgium+32-2-29-93669 (phone)+32-2-29-57332 (fax)philippe.martin (at) ec.europa.eu